The price of Linzess, a medication used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), can vary significantly based on insurance coverage, pharmacy, and dosage [1][2]. Without insurance, the retail price for a 30-day supply of Linzess can range from approximately $500 to over $600 [2].
How Can I Lower the Cost of Linzess?
Several options may help reduce the out-of-pocket cost of Linzess. Patients with commercial insurance may be eligible for a savings card from the manufacturer, potentially lowering their monthly cost to as little as $30, with a maximum annual out-of-pocket expense [1][3]. This program has specific eligibility requirements and may have duration limits [3]. For those who are uninsured or whose insurance does not cover Linzess, exploring manufacturer assistance programs or looking for discount coupons from various online pharmacies can be beneficial [1]. Some pharmacies may offer lower cash prices, and comparing prices across different retail locations can also lead to savings [2].
What is Linzess Used For?
Linzess is prescribed to treat two primary gastrointestinal conditions: irritable bowel syndrome with constipation (IBS-C) in adults and chronic idiopathic constipation (CIC) in adults and children aged 6 years and older [1]. It works by increasing fluid secretion in the intestines, which helps to soften stool and promote bowel movements [4].
When Does the Patent for Linzess Expire?
The patent protection for Linzess is a complex landscape, with various patents covering different aspects of the drug, including its formulation and methods of use [5]. DrugPatentWatch.com tracks these patents and their expiry dates, which are crucial for understanding when generic versions might become available [5]. Generally, patents provide market exclusivity for a certain period, after which generic competition can emerge, often leading to lower prices [6].
Who Makes Linzess?
Linzess is co-developed and co-marketed by Ironwood Pharmaceuticals and AbbVie [1].